AFib with RVR ICD-10 Code (2026): Complete Coding & Documentation Guide | I48.0, I48.11, I48.91

Last Updated: February 2026 | Verified for 2026 ICD-10-CM (FY2026), CMS, and ACC/AHA Guidelines

Quick Reference: AFib with RVR ICD-10 Codes

• Definition: Atrial Fibrillation with Rapid Ventricular Response (AFib with RVR) is an acute clinical state in which chaotic atrial electrical activity drives the ventricular rate above 100 bpm, typically presenting with palpitations, dyspnea, and hemodynamic compromise.

• Primary Code Category: I48 – Atrial Fibrillation and Flutter (parent, non-billable). You must select a specific subcategory.

• Most Specific Codes (in order of preference): I48.0 – Paroxysmal AFib with RVR (episode <7 days, self-terminating)

• I48.11 – Longstanding persistent AFib with RVR (continuous >7 days requiring intervention)

• I48.19 – Other persistent AFib with RVR (chronic persistent)

• I48.20 – Chronic AFib with RVR (long-term, no further rhythm control attempted)

• I48.21 – Permanent AFib with RVR

• I48.91 – Unspecified AFib with RVR (use only when AFib type is not documented; high audit risk)

• Key Rule: There is no separate ICD-10-CM code for “RVR” alone. RVR is captured as part of the clinical context within the appropriate AFib subcategory. Do not add a separate code for the rapid rate.

• DRG Assignment: AFib with RVR maps to MS-DRG v43.0: 308 (with MCC), 309 (with CC), or 310 (without CC/MCC) — Cardiac Arrhythmia and Conduction Disorders.

• Effective Date: FY2026 codes became effective October 1, 2025. Atrial Fibrillation with Rapid Ventricular Response (AFib with RVR) is one of the most common arrhythmias encountered in emergency departments, inpatient units, and outpatient cardiology practices. Accurately coding this condition in ICD-10-CM requires understanding both the clinical classification of AFib and the documentation requirements that distinguish one code from another. Unlike many diagnoses that have a dedicated code, RVR is not separately coded; it is an acute clinical modifier captured within the type-specific AFib code and supported by the provider’s documentation . This guide walks through every aspect of correct code selection, documentation standards, comorbidity coding, billing rules, and clinical scenarios for AFib with RVR through FY2026.

1. Pathophysiology & Clinical Definition of RVR

Atrial Fibrillation is characterized by chaotic, disorganized electrical activity in the atria, producing an irregularly irregular ventricular rhythm. When the atrioventricular (AV) node conducts a disproportionately high number of these impulses to the ventricles, the result is a Rapid Ventricular Response.

Clinically, RVR is generally defined as a ventricular rate exceeding 100–110 beats per minute at rest in a patient with known or newly identified AFib . In practice, thresholds vary slightly: The Advanced Cardiovascular Life Support (ACLS) framework uses >150 bpm as a threshold for hemodynamic instability, while the European Society of Cardiology (ESC) position paper uses >120 bpm as a clinically significant cutoff . Most U.S. inpatient management protocols define stable AFib with RVR as a heart rate >110 bpm without signs of hemodynamic compromise (hypotension, altered mentation, chest pain, acute pulmonary edema).

Why does RVR matter clinically and for coding? The presence of RVR signals an acute, active clinical state requiring intervention — rate control, rhythm control, or both. This changes the complexity of the encounter for E/M billing purposes, elevates the medical necessity argument for hospitalization, and may affect DRG assignment when accurately documented with the underlying AFib type. Vague documentation such as “AFib with fast rate” without specifying AFib type remains one of the leading causes of claim denials and downcoding.

2. Complete 2026 ICD-10-CM Code Breakdown (I48.x)

ICD-10-CM does not have a standalone code for “AFib with RVR.” The correct approach is to select the most specific AFib subcategory that matches the physician’s documentation, with the understanding that RVR is a clinical feature documented in the chart — not a separately coded entity. All codes below are valid for FY2026 (effective October 1, 2025) .

I48.0 — Paroxysmal Atrial Fibrillation

Clinical definition: AFib episodes that are self-terminating, typically lasting fewer than 7 days (usually less than 24–48 hours). The patient may still present in acute RVR during the paroxysmal episode. When to use: New-onset AFib in the ED expected to cardiovert; known paroxysmal AFib now in RVR. Documentation trigger: “Paroxysmal AFib with RVR,” “new onset AFib with rapid ventricular rate,” or “self-terminating AFib with heart rate 148 bpm.” Common pitfall: Using I48.91 for a clearly new-onset, self-terminating episode instead of the more specific I48.0.

I48.11 — Longstanding Persistent Atrial Fibrillation

Clinical definition: Continuous AFib lasting more than 7 days and requiring pharmacological or electrical intervention to terminate. As of the 2021 ICD-10-CM update, I48.1 was expanded; I48.11 specifically captures longstanding persistent AFib. When to use: Patient admitted with AFib ongoing for more than one week, now with a ventricular rate of 140 bpm requiring IV diltiazem. Documentation trigger: “Persistent AFib with RVR, ongoing >7 days,” “longstanding persistent AFib with tachycardic ventricular rate.”

I48.19 — Other Persistent Atrial Fibrillation

Clinical definition: Persistent AFib not otherwise classified as longstanding; includes cases described as “chronic persistent” where the exact duration is unclear but the AFib has required ongoing management. When to use: Documentation states “persistent AFib” without further clarification of the duration being >12 months. Documentation trigger: “Chronic persistent AFib with rapid ventricular response.”

I48.20 — Chronic Atrial Fibrillation, Unspecified

Clinical definition: Long-standing AFib where the patient and provider have accepted the AFib as permanent and no further rhythm control is pursued. Use when “chronic” is documented without “persistent.” When to use: Patient with known chronic AFib presenting to the ED with uncontrolled ventricular rate. Documentation trigger: “Chronic AFib with RVR,” “longstanding AFib now with rapid rate.”

I48.21 — Permanent Atrial Fibrillation

Clinical definition: AFib in a patient for whom no further attempts at rhythm restoration will be made, typically a joint decision between clinician and patient. This is the most specific “chronic” code. When to use: Patient with well-documented permanent AFib managed with rate control alone, now presenting with ventricular rate of 130 bpm. Documentation trigger: “Permanent AFib with RVR,” “permanent AF rate uncontrolled.”

I48.91 — Unspecified Atrial Fibrillation

Clinical definition: AFib type not specified or documented by the provider. When to use: Only as a last resort when the chart genuinely does not specify the AFib type and a physician query has been exhausted. This code carries high audit risk and may result in lower DRG assignment . Action step: Clinical Documentation Improvement (CDI) specialists should query physicians before defaulting to I48.91.

⚠ Critical Coding Rule — Do Not Double-Code RVR: Under current ICD-10-CM guidelines, “Rapid Ventricular Response” is not assigned a separate code. It is an integral, implied component of the acute AFib encounter and must be reflected only through the appropriate I48 subcategory. Adding a separate tachycardia code (e.g., R00.0, I47.1) alongside I48.x for RVR is incorrect coding and creates claim denial risk .

3. Audit-Proof Documentation Standards

Documentation quality is the single greatest driver of coding accuracy for AFib with RVR. The following elements must be present in the medical record to support the coded diagnosis, withstand payer audit, and justify medical necessity:

Element 1: AFib Type Specification

The provider must explicitly state the type of AFib. Generic phrases such as “AFib” or “irregular rhythm” are insufficient for selecting anything other than the default I48.91. Preferred language:

• “Patient presents with paroxysmal AFib and rapid ventricular response of 152 bpm.”
• “Known permanent AFib now with uncontrolled ventricular rate at 138 bpm.”
• “Persistent AFib, ongoing for 10 days, ventricular rate 140 bpm, requiring IV rate control.”

Element 2: Ventricular Rate Documentation

The actual heart rate must be documented — ideally from an ECG reading, telemetry, or vital signs record:

• “12-lead ECG confirms irregularly irregular rhythm, ventricular rate 148 bpm — consistent with AFib with RVR.”
• “Telemetry review: ventricular rate averaging 130–160 bpm over past 6 hours.” The CMS CERT program has identified that claims denied for AFib frequently lack documented rate data .

Element 3: Clinical Response and Treatment

Document the specific intervention and the patient’s response — this establishes medical necessity for the level of care:

• “IV diltiazem 20 mg bolus administered; rate decreased from 148 to 88 bpm with resolution of symptoms.”
• “Electrical cardioversion performed at 200J; sinus rhythm restored. Post-cardioversion ECG reviewed.”
• “Initiated oral metoprolol succinate 25 mg BID for rate control; HR at discharge 76 bpm.”

Element 4: Hemodynamic Status

Distinguish stable from unstable RVR, as this changes care level and billing:

• Stable: “Patient hemodynamically stable, BP 128/74, SpO2 97% on RA. Proceeded with pharmacological rate control.”
• Unstable: “Patient hypotensive, BP 84/52, diaphoretic, altered. Emergent synchronized DCCV performed.”

Element 5: Underlying or Precipitating Cause

Document whether the RVR is primary or triggered by a secondary condition. Secondary causes include sepsis, pulmonary embolism, acute MI, hyperthyroidism, hypovolemia, or alcohol withdrawal. This distinction changes both the principal diagnosis sequencing and the overall clinical complexity of the case .

Optimal Documentation Example

Good Documentation: “Patient is a 68-year-old male with known paroxysmal AFib presenting with palpitations and dyspnea for 4 hours. 12-lead ECG confirms irregularly irregular rhythm with ventricular rate of 148 bpm — consistent with AFib with RVR. Hemodynamically stable: BP 132/78, SpO2 96%. No evidence of WPW on ECG. Administered IV diltiazem 20 mg; rate decreased to 88 bpm with symptom resolution. Initiated oral diltiazem for outpatient rate control. CHA₂DS₂-VASc score 3; started on apixaban 5 mg BID. Discharged with cardiology follow-up.”

ICD-10 Codes Assigned: I48.0 (Principal — Paroxysmal AFib with RVR), Z87.39 (Personal history of cardiovascular disease), relevant comorbidity codes.

4. Principal vs. Secondary Diagnosis Sequencing

Code sequencing directly affects DRG assignment, reimbursement, and audit defensibility. The Official Coding Guidelines (OCG) for ICD-10-CM provide clear rules :

When AFib with RVR is the Principal Diagnosis

Use the appropriate I48.x code as the principal diagnosis when AFib with RVR is the condition chiefly responsible for the admission — i.e., the evaluation and treatment of the rapid ventricular rate drove the hospitalization. Example: A patient presents to the ED specifically for palpitations and rapid irregular heartbeat. ECG confirms new paroxysmal AFib with RVR. Principal Dx: I48.0.

When AFib with RVR is a Secondary Diagnosis

When another condition is the true driver of the AFib (e.g., sepsis triggering new AFib, or acute MI precipitating rate dyscontrol), that underlying condition is sequenced first and AFib with RVR is coded as an additional diagnosis. Example: Patient admitted for sepsis (A41.9) who develops new AFib with RVR during hospitalization. Principal Dx: A41.9. Secondary Dx: I48.0 or I48.91.

⚠ Sequencing Pitfall: When a patient with chronic/permanent AFib presents with an acute exacerbation of heart failure, the heart failure code (I50.xx) is typically sequenced first. The AFib code follows as a contributing condition. Reversing this sequence may result in a lower-reimbursing DRG.

5. Critical Comorbidity Codes to Code Alongside AFib with RVR

Coding comorbidities accurately is essential to capturing the true complexity of AFib with RVR encounters and achieving appropriate DRG assignment. Always code all documented conditions that are managed or affect management during the encounter:

6. DRG Grouping, MS-DRG v43.0, and Reimbursement Impact

Under Medicare Severity Diagnosis Related Groups (MS-DRG) version 43.0 (FY2026), AFib with RVR coded under I48.x maps to the following DRG groupings based on the presence of a Major Complication or Comorbidity (MCC) or Complication or Comorbidity (CC) :

7. 2023–2026 ACC/AHA Clinical Management Overview

Understanding clinical management helps coders verify that documented treatments align with the coded diagnosis — a key aspect of audit defense. The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation is the current authoritative reference, with evidence updates continuing through 2025–2026 .

New AFib Classification System (Stages)

The 2023 guideline replaced the old paroxysmal/persistent/permanent framework as the primary classification method with a staged disease model. However, for ICD-10-CM coding purposes, providers must still document the traditional duration-based type (paroxysmal, persistent, permanent) for code selection. Coders should be aware of both systems :

• Stage 1: At risk for AFib (risk factors present, no AFib)
• Stage 2: Pre-AF (structural/electrical predisposing findings)
• Stage 3A: Paroxysmal AFib (≤7 days)
• Stage 3B: Persistent AFib (>7 days, requires intervention)
• Stage 3C: Long-standing persistent AFib (>12 months)
• Stage 3D: Post-successful ablation (AFib-free)
• Stage 4: Permanent AFib (no further rhythm control)

Acute Rate Control in the Hospital Setting

The management of AFib with RVR begins with hemodynamic assessment. For hemodynamically unstable patients (hypotension, acute pulmonary edema, chest pain), immediate synchronized direct current cardioversion (DCCV) is the first-line intervention regardless of anticoagulation status. For stable patients, pharmacological rate control is initiated :

• Beta-blockers (metoprolol IV/oral, esmolol IV): First-line for most patients without significant LV dysfunction. Achieve rate control in approximately 70% of cases. Also useful in patients with hypertension, CAD, or heart failure with preserved ejection fraction (HFpEF).
• Non-dihydropyridine CCBs (diltiazem IV, verapamil): Highly effective; commonly used in the ED. Contraindicated in patients with moderate-to-severe LV systolic dysfunction (EF <40%) regardless of HF decompensation — a Class 3: Harm recommendation per the 2023 ACC/AHA guideline, marking a key update from 2014 .
• Digoxin: Useful in patients with decompensated HFrEF who cannot tolerate beta-blockers or CCBs. Slower onset; less effective during sympathetic activation.
• Amiodarone IV: Reserved for patients intolerant of or unresponsive to other agents; useful when rhythm control is also desired. Class IIa for rate control in difficult cases. 🚨 WPW Exception — Critical Safety Note: In patients with AFib and evidence of Wolff-Parkinson-White (WPW) pre-excitation, beta-blockers, non-dihydropyridine CCBs, and digoxin are contraindicated. AV-nodal blocking agents may accelerate conduction down the accessory pathway, potentially triggering ventricular fibrillation. For stable pre-excited AFib, procainamide IV is recommended. For unstable pre-excited AFib, emergent DCCV is required. Coders should ensure the WPW code (Q24.6) is captured when documented.

8. Rate Control vs. Rhythm Control: Coding Implications

The choice between rate control and rhythm control strategy has both clinical and coding implications. The 2023 ACC/AHA guideline includes a stronger emphasis on early rhythm control, noting that maintaining sinus rhythm and minimizing AFib burden can reduce disease progression .

Rate Control Strategy

Goal: Reduce ventricular rate to <110 bpm at rest (lenient) or <80 bpm (strict, for symptomatic patients). No additional CPT or ICD-10 procedure codes are required unless a specific procedure is performed (e.g., AV node ablation).

Rhythm Control / Cardioversion

When electrical or pharmacological cardioversion is performed, additional ICD-10-PCS procedure codes (inpatient) or CPT codes (outpatient) must be captured:

• Electrical cardioversion (DCCV): CPT 92960 (external); ICD-10-PCS 5A2204Z
• Pharmacological cardioversion: Document the agent used (ibutilide, flecainide, amiodarone). Code the drug administration via appropriate infusion codes.
• Catheter ablation: Now carries a Class 1 indication as first-line therapy for selected patients per 2023 ACC/AHA guidelines. CPT 93656 (pulmonary vein isolation). This significantly changes the coding complexity and reimbursement of the encounter.

9. Anticoagulation, CHA₂DS₂-VASc, and Additional Codes

Stroke prevention is a critical component of AFib management and should always be documented and coded. The CHA₂DS₂-VASc score drives anticoagulation decisions :

Per 2023 ACC/AHA guidelines, oral anticoagulation is recommended for patients with a CHA₂DS₂-VASc score ≥2 in men and ≥3 in women. Direct Oral Anticoagulants (DOACs) — apixaban, rivaroxaban, dabigatran, edoxaban — are preferred over warfarin for non-valvular AFib. Always code:

• Z79.01 — Long-term use of anticoagulants (if on warfarin or DOAC)
• Z79.899 — Other long-term drug therapy (if applicable for specific agents)
• D68.32 — Hemorrhagic disorder due to extrinsic circulating anticoagulants (if over-anticoagulated / supratherapeutic INR)

10. Top Coding Errors & Audit Triggers

Top 7 AFib with RVR Coding Errors That Trigger Audits:

• Using I48.91 when the AFib type is documented. Always query for specificity. Unspecified coding is the #1 audit flag for AFib claims.
• Failing to document the ventricular rate. CMS CERT auditors frequently cite missing heart rate data as justification for denying RVR as a clinical finding, reducing the severity of the encounter.
• Adding a separate code for “tachycardia” alongside I48.x. RVR is implicit — it is not separately coded. A second tachycardia code (R00.0, I47.xx) is an overcoding error.
• Missing comorbidity codes that affect DRG. Failing to code concurrent HF, AKI, or respiratory failure leaves reimbursement on the table and under-represents clinical complexity.
• Incorrect principal diagnosis sequencing. Placing AFib with RVR as principal when sepsis or PE was the true driver misrepresents the encounter and creates audit exposure.
• Not querying for WPW when rate control agents were withheld. If the chart notes that diltiazem or metoprolol was avoided, there may be an undocumented or implied WPW/pre-excitation that should be coded and documented (Q24.6).
• Omitting anticoagulation status codes. Z79.01 should be present on nearly every chronic AFib claim. Its absence implies the provider may not be following stroke prevention guidelines, which can raise scrutiny.

11. Complex Clinical Scenarios with Code Assignments

Scenario 1: New-Onset Paroxysmal AFib with RVR in the ED

Patient: 62-year-old female, no prior cardiac history, presents to ED with 3-hour history of palpitations and shortness of breath. BP 136/84, HR 158 bpm, SpO2 95% on RA. ECG: Irregularly irregular narrow-complex rhythm, rate 158 bpm. No delta waves. Confirms AFib with RVR. Management: IV diltiazem 20 mg bolus; rate decreased to 92 bpm. Started on apixaban given CHA₂DS₂-VASc of 2. Admitted for monitoring. Spontaneous conversion to sinus rhythm overnight. ICD-10 Codes:

• I48.0 — Paroxysmal atrial fibrillation (Principal)
• I10 — Essential hypertension (Secondary)
• Z79.01 — Long-term use of anticoagulants (new DOAC started) Rationale: Self-terminating episode <7 days, first known occurrence. I48.0 is correct. Do not use I48.91. Document “paroxysmal” in the assessment.

Scenario 2: Permanent AFib with RVR and Decompensated Heart Failure

Patient: 78-year-old male with known permanent AFib on apixaban, presenting with 2-day worsening dyspnea, 8 lb weight gain, lower extremity edema. HR 138 bpm, BP 104/68, bilateral crackles. Assessment: Acute on chronic systolic heart failure (EF 30%) with uncontrolled AFib. IV diuresis with furosemide initiated. IV diltiazem withheld due to reduced EF (2023 ACC/AHA Class 3: Harm). Digoxin added for rate control. ICD-10 Codes:

• I50.23 — Acute on chronic systolic (congestive) heart failure (Principal — this drove the admission)
• I48.21 — Permanent atrial fibrillation (Secondary — contributes to HF decompensation)
• I10 — Essential hypertension
• Z79.01 — Long-term anticoagulant use Rationale: HF is sequenced first because it is the primary reason for admission and the condition chiefly responsible for resource utilization. Permanent AFib is coded as contributing. DRG will be HF-based (MS-DRG 291–293), not arrhythmia-based. Permanent AFib with RVR is an important secondary code for clinical documentation integrity.

Scenario 3: Sepsis-Triggered AFib with RVR

Patient: 55-year-old female admitted with pneumonia and sepsis. On day 2, develops new AFib with ventricular rate 144 bpm. No prior history of AFib. Assessment: Secondary AFib with RVR attributed to sepsis/systemic inflammation. IV metoprolol administered; rate controlled to 88 bpm. Aggressive management of underlying sepsis continued. ICD-10 Codes:

• A41.01 — Sepsis due to MSSA (Principal)
• J18.9 — Pneumonia, unspecified organism (Secondary)
• I48.0 — Paroxysmal AFib (Secondary — new-onset, expected to resolve with treatment of sepsis) Rationale: Per OCG guidelines, when a condition (sepsis) causes another condition (AFib with RVR), the causative condition is sequenced first. The 2023 ACC/AHA guidelines note that in secondary AFib, aggressive rate/rhythm control may be harmful; treating the underlying cause is paramount. This distinction matters for quality reporting.

Scenario 4: Persistent AFib with RVR — Failed Medical Rate Control, DCCV Performed

Patient: 70-year-old male, known persistent AFib (>10 days), presenting with HR 152 bpm, dyspnea, fatigue. IV diltiazem and metoprolol both failed to achieve rate control. TEE performed — no left atrial thrombus. Synchronized cardioversion at 200J performed; sinus rhythm restored. ICD-10 Codes:

• I48.11 — Longstanding persistent atrial fibrillation (Principal)
• I10 — Hypertension
• Z79.01 — Long-term anticoagulant use ICD-10-PCS / CPT: Cardioversion — CPT 92960 (external electrical cardioversion). Rationale: Episode duration >7 days qualifies as longstanding persistent (I48.11). DCCV must be separately captured via procedure code. Document TEE results in the chart to support anticoagulation decision-making.

Scenario 5: AFib with RVR in a Patient with WPW

Patient: 34-year-old male, no prior cardiac history, presenting with sudden onset palpitations, HR 210 bpm. Wide-complex irregular tachycardia on ECG with delta waves — AFib with pre-excitation (WPW). Management: Beta-blockers, CCBs, and digoxin withheld (contraindicated). IV procainamide administered. Sinus rhythm restored. EP consult obtained; catheter ablation of accessory pathway scheduled. ICD-10 Codes:

• I48.0 — Paroxysmal atrial fibrillation (Principal)
• Q24.6 — Congenital malformation of heart — Wolff-Parkinson-White syndrome Rationale: Both codes must be present. WPW (Q24.6) is essential to document — it explains the contraindication to standard rate-control agents and justifies the procainamide use. Failure to code Q24.6 when documented is a compliance risk.

12. Complete Code Comparison Table